enGene Therapeutics Inc.
Biotechnology company · Saint-Laurent, Quebec, Canada · Nasdaq: ENGN
enGene Therapeutics Inc. is a biotechnology company headquartered in Saint-Laurent, Quebec, Canada. Its shares trade on Nasdaq under the ticker ENGN.
Profile compiled from public records. Is this your company? Request a correction or update
enGene Therapeutics at a glance
Typebiotechnology company
HeadquartersSaint-Laurent, Quebec, Canada
Stock listingNasdaq: ENGN
SEC industryBiological Products, (No Diagnostic Substances)
SEC CIK1980845
Frequently asked questions about enGene Therapeutics
Where is enGene Therapeutics headquartered?
enGene Therapeutics Inc. is headquartered in Saint-Laurent, Quebec, Canada.
What does enGene Therapeutics do?
enGene Therapeutics Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is enGene Therapeutics a public company?
Yes. enGene Therapeutics Inc. trades on Nasdaq under the ticker ENGN.
Similar companies
- Aptose Biosciences Inc.Toronto, Ontario, Canada
- Cardiol Therapeutics Inc.Oakville, Ontario, Canada
- Orion Biotechnology Canada Ltd.Ottawa, Ontario, Canada
- ARC Medical Inc.Richmond, British Columbia, Canada
- Zucara Therapeutics Inc.Toronto, Ontario, Canada
- Soricimed Biopharma Inc.Moncton, New Brunswick, Canada
- Appili Therapeutics Inc.Halifax, Nova Scotia, Canada
- Therma Bright Inc.Toronto, Ontario, Canada
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences